An Imaging Study to Investigate the Distribution of GSK239512 in the Brain.

NCT00474513 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

5

Enrollment

INDUSTRY

Sponsor class

Conditions

Mild Cognitive Impairment
Dementia

Interventions

DRUG: GSK239512

Sponsor

GlaxoSmithKline